CAPTRUST Financial Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

CAPTRUST Financial Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-520	Closed	-$12K	–	4824
2021 Q1	$12K	Buy	+520	New	+$9.66K	﹤0.01%	3354

CAPTRUST Financial Advisors's GNMK Position: Q2 2021 in Review

CAPTRUST Financial Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 520 shares — an estimated $12K sold.

CAPTRUST Financial Advisors first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $12K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

CAPTRUST Financial Advisors reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
CAPTRUST Financial Advisors sold 520 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $12K.
CAPTRUST Financial Advisors first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
CAPTRUST Financial Advisors's GenMark Diagnostics, Inc position peaked at $12K in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.